Is electroconvulsive therapy (ECT) used to treat substance use disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ECT is Not a Standard Treatment for Substance Use Disorders

ECT is not used as a primary treatment for substance use disorders themselves, but may be indicated when severe, treatment-resistant mood disorders co-occur with substance abuse. The evidence focuses on ECT's role in treating underlying psychiatric conditions (major depression, bipolar disorder, catatonia) rather than addiction directly.

Primary Indications for ECT

ECT is indicated for specific psychiatric conditions, not substance abuse:

  • Severe, persistent major depression or mania with or without psychotic features, particularly when treatment-resistant 1
  • Catatonia and neuroleptic malignant syndrome as primary targets 1, 2
  • Schizoaffective disorder or schizophrenia in select cases 1
  • Life-threatening symptoms including refusal to eat/drink, severe suicidality, uncontrollable mania, and florid psychosis 1

ECT in Patients with Comorbid Substance Use

When substance use disorders co-exist with mood disorders requiring ECT, the evidence shows:

  • Comorbid alcohol or drug abuse alone does not contraindicate ECT and patients can still achieve symptom improvement 3
  • Alcohol abuse as a single comorbidity showed no significant difference in ECT outcomes compared to patients without substance abuse (89% vs 93% improvement, p=0.086) 3
  • Combined drug and alcohol abuse resulted in significantly worse outcomes (82% vs 93% improvement, p=0.033), though patients still improved 3
  • Substance dependence (versus abuse) showed a trend toward poorer response (83% vs 93% improvement, p=0.053) 3

Clinical Decision Algorithm

When considering ECT in patients with substance use disorders:

  1. Identify the primary psychiatric diagnosis - ECT treats the mood disorder, bipolar disorder, or catatonia, not the addiction 1

  2. Document treatment resistance - At least two adequate medication trials must have failed for the psychiatric condition 1, 4

  3. Assess severity - Symptoms must be severe, persistent, and significantly disabling 1

  4. Evaluate substance use pattern:

    • Single substance abuse: Proceed with ECT as indicated 3
    • Dependence or combined drug/alcohol abuse: Expect potentially reduced but still meaningful response 3
    • Active withdrawal states: Manage withdrawal first (benzodiazepines for alcohol/benzodiazepine withdrawal) 5

Critical Pitfalls to Avoid

  • Do not use ECT to treat addiction itself - there is no evidence supporting ECT as a treatment for substance use disorders as a primary indication 1, 3
  • Do not exclude patients from ECT solely based on substance abuse history - comorbid substance use is not a contraindication, though it may reduce efficacy 3
  • Do not overlook that substance-induced psychotic disorder requires different management - ensure symptoms persist beyond acute intoxication/withdrawal to confirm primary psychiatric illness 2
  • Do not continue benzodiazepines during ECT unless medically necessary (e.g., active withdrawal), as they reduce ECT efficacy 5

Expected Outcomes

  • Patients with mood disorders and comorbid substance abuse show significant improvement with ECT, though response may be attenuated compared to those without substance use 3
  • Combined substance abuse and dependence predict somewhat reduced efficacy but not treatment failure 3
  • The underlying psychiatric condition (depression, mania, catatonia) responds to ECT according to established response rates (60-80% for treatment-resistant depression, 70-100% for bipolar disorder) 1, 4, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Catatonia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ECT for Treatment-Resistant Somatic Symptom Disorder with Anxiety in Bipolar I Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Benzodiazepines and ECT Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is Electroconvulsive Therapy (ECT) effective?
What is the role of electroconvulsive therapy (ECT) in treating severe, treatment-resistant depression in patients who have not responded to multiple antidepressant medications?
Is Electroconvulsive Therapy (ECT) a viable treatment option for patients with treatment-resistant Somatic Symptom Disorder (SSD)?
What is the role of Electroconvulsive Therapy (ECT) in treating psychiatric conditions?
What is the best course of treatment for a patient with severe mental illness who remains actively psychotic despite undergoing electroconvulsive therapy (ECT)?
What is the recommended initial assessment and step‑by‑step management of cardiogenic shock, including monitoring, pharmacologic and fluid therapy, treatment of the underlying cause, and when to use mechanical circulatory support?
At what minimum age can Augmentin (amoxicillin‑clavulanate) be started in children?
In a 9‑year‑old boy with acute lymphoblastic leukemia who is 36 days post‑haploidentical hematopoietic stem‑cell transplant and now has decreasing hemoglobin and platelet counts, schistocytes on peripheral smear, elevated lactate dehydrogenase, and a urine protein‑creatinine ratio of 0.2 mg/mg, what is the most likely diagnosis?
What is the differential diagnosis, appropriate work‑up, and management for a swollen lower extremity with a small wound?
What are the dosing guidelines, contraindications, safety considerations, and alternative antiemetics for ondansetron in adults and children?
What is the first step in managing sexual side effects in a patient with major depressive disorder on sertraline (Zoloft) 100 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.